AU Patent

AU2010259023A1 — Triazine derivatives and their therapeutical applications

Assigned to NantBioscience Inc · Expires 2012-01-12 · 14y expired

What this patent protects

Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.

USPTO Abstract

Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.

Drugs covered by this patent

Gavreto (PRALSETINIB) · Rigel Pharms

Patent Metadata

Patent number: AU2010259023A1
Jurisdiction: AU
Classification: —
Expires: 2012-01-12
Drug substance claim: No
Drug product claim: No
Assignee: NantBioscience Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.